Distinct microenvironment phenotypes across tumor, vascular, and immune compartments from ramucirumab plus pembrolizumab in refractory gastric cancer: A phase II trial.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Samsung Medical Center, Sungkyunkwan University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410816490
